Owner/Developer: Evercyte GmbH
Evercyte establishes immortalized cell lines that retain key functionalities of the corresponding
primary cells and has put a focus on the development of patient specific human iPS cell lines from urine-derived cells, which can be differentiated into any cell of the three germ layers. Evercyte’s cell cultures find their applications as model systems in basic research as well as in pharmaceutical, chemical and cosmetic industries as well as in ecotoxicology. In close collaboration with our clients we also develop novel cell lines from human tissues and establish innovative in vitro test systems to answer our clients’ specific questions.
|Audience:||Scientists - Industry - Researchers|
|User access:||Open access|
|Updating frequency:||Frequently updated|
|Relevance:||Replacement - Reduction|
|Purpose:||Fundamental studies - Toxicological and safety evaluation - Method development|
|Technology/Tools:||Alternative test methods (in vitro) - Stem cells|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.